These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 24094495)

  • 1. Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients.
    Janukonyté J; Parkner T; Lauritzen T; Christiansen JS; Laursen T
    Growth Horm IGF Res; 2013 Dec; 23(6):256-60. PubMed ID: 24094495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of moderate interval exercise versus supine rest on the pharmacokinetics and pharmacodynamic profiles of subcutaneously administered growth hormone in adult growth hormone deficient patients.
    Janukonytė J; Parkner T; Lauritzen T; Christiansen JS; Frystyk J; Pedersen HS; Laursen T
    Growth Horm IGF Res; 2014 Oct; 24(5):198-204. PubMed ID: 25037883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of continuous and intermittent patterns of growth hormone administration on lipoprotein levels in growth hormone-deficient patients.
    Laursen T; Lemming L; Jørgensen JO; Klausen IC; Christiansen JS
    Horm Res; 1998; 50(5):284-91. PubMed ID: 9873197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites.
    Jørgensen JO; Møller N; Lauritzen T; Alberti KG; Orskov H; Christiansen JS
    J Clin Endocrinol Metab; 1990 Jan; 70(1):207-14. PubMed ID: 2294131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled growth hormone (GH) compared with subcutaneous GH in children with GH deficiency: pharmacokinetics, pharmacodynamics, and safety.
    Walvoord EC; de la Peña A; Park S; Silverman B; Cuttler L; Rose SR; Cutler G; Drop S; Chipman JJ
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2052-9. PubMed ID: 19336514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single and multiple dose pharmacokinetics of methionyl growth hormone in children with idiopathic growth hormone deficiency.
    Kearns GL; Kemp SF; Frindik JP
    J Clin Endocrinol Metab; 1991 May; 72(5):1148-56. PubMed ID: 2022713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels but preserved diurnal variation of serum leptin in GH-deficient patients: lack of impact of different modes of GH administration.
    Nørrelund H; Gravholt CH; Englaro P; Blum WF; Rascher W; Chistiansen JS; Jørgensen JO
    Eur J Endocrinol; 1998 Jun; 138(6):644-52. PubMed ID: 9678531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new sustained-release preparation of human growth hormone and its pharmacokinetic, pharmacodynamic and safety profile.
    Jostel A; Mukherjee A; Alenfall J; Smethurst L; Shalet SM
    Clin Endocrinol (Oxf); 2005 May; 62(5):623-7. PubMed ID: 15853836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
    Björnsdottir S; Øksnes M; Isaksson M; Methlie P; Nilsen RM; Hustad S; Kämpe O; Hulting AL; Husebye ES; Løvås K; Nyström T; Bensing S
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of growth hormone treatment on serum bone alkaline phosphatase in growth hormone deficient children.
    Korpal-Szczyrska M; Balcerska A
    Pediatr Endocrinol Diabetes Metab; 2008; 14(4):211-4. PubMed ID: 19239787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A first-in-man phase 1 trial for long-acting TransCon Growth Hormone.
    Gilfoyle D; Mortensen E; Christoffersen ED; Leff JA; Beckert M
    Growth Horm IGF Res; 2018 Apr; 39():34-39. PubMed ID: 29273485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in insulin sensitivity induced by short-term growth hormone (GH) and insulin-like growth factor I (IGF-I) treatment in GH-deficient adults are not associated with changes in adiponectin levels.
    Schmid C; Bianda T; Zwimpfer C; Zapf J; Wiesli P
    Growth Horm IGF Res; 2005 Aug; 15(4):300-3. PubMed ID: 16054413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset.
    Columb B; Smethurst LE; Mukherjee A; Jostel A; Shalet SM; Murray RD
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):281-6. PubMed ID: 18702681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad variability in pharmacokinetics of GH following rhGH injections in children.
    Lundberg E; Andersson B; Kriström B; Rosberg S; Albertsson-Wikland K
    Growth Horm IGF Res; 2018 Jun; 40():61-68. PubMed ID: 29422321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of fasting and treatment omission on susceptibility to hypoglycaemia in children and adolescents with GH and cortisol insufficiency.
    Johnstone HC; McNally RJ; Cheetham TD
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):436-42. PubMed ID: 18248651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men.
    de Boer H; Blok GJ; Voerman B; Derriks P; van der Veen E
    Int J Obes Relat Metab Disord; 1996 Jun; 20(6):580-7. PubMed ID: 8782736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.